These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16344278)

  • 1. A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer.
    Twelves C; Gollins S; Grieve R; Samuel L
    Ann Oncol; 2006 Feb; 17(2):239-45. PubMed ID: 16344278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwanese stage III colorectal cancer patients based on quality-of-life measures (QLQ-C30 and QLQ-CR38) and a new cost assessment tool.
    Lin JK; Tan EC; Yang MC
    Health Qual Life Outcomes; 2015 May; 13():61. PubMed ID: 25986478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer.
    Ward SE; Kaltenthaler E; Cowan J; Marples M; Orr B; Seymour MT
    Br J Cancer; 2006 Jul; 95(1):27-34. PubMed ID: 16804526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study).
    Kinos S; Hagman H; Halonen P; Soveri LM; O'Reilly M; Pfeiffer P; Frödin JE; Sorbye H; Heervä E; Liposits G; Kallio R; Ålgars A; Ristamäki R; Salminen T; Bärlund M; Shah CH; McDermott R; Röckert R; Flygare P; Kwakman J; Teske A; Punt C; Glimelius B; Österlund P
    Acta Oncol; 2024 May; 63():248-258. PubMed ID: 38698698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorouracil Induced Hypertriglyceridemia During the Colorectal Cancer Treatment in a Patient With Multifactorial Chylomicronemia Syndrome: A Case Report.
    Penesova A; Minarik P; Huckova M; Vlcek M; Szantova M; Krizanova O
    Clin Ther; 2024 May; 46(5):429-432. PubMed ID: 38763818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer.
    Almond J; Ralston S
    Br J Cancer; 2007 May; 96(9):1489; author reply 1490. PubMed ID: 17437019
    [No Abstract]   [Full Text] [Related]  

  • 7. A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring - supporting patients in their homes.
    Weaver A; Love SB; Larsen M; Shanyinde M; Waters R; Grainger L; Shearwood V; Brooks C; Gibson O; Young AM; Tarassenko L
    Support Care Cancer; 2014 Oct; 22(10):2677-85. PubMed ID: 24771299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial.
    Borras JM; Sanchez-Hernandez A; Navarro M; Martinez M; Mendez E; Ponton JL; Espinas JA; Germa JR
    BMJ; 2001 Apr; 322(7290):826. PubMed ID: 11290635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of metastatic colorectal cancer with prolonged liver injury following capecitabine combination chemotherapy.
    Takada T; Katoh R; Yamada K; Ojima H
    BMJ Case Rep; 2024 Jul; 17(7):. PubMed ID: 38969391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate continuation of medication when patients are admitted acutely: the example of capecitabine.
    Booth JA; Booth C; Crawford SM
    Clin Med (Lond); 2011 Oct; 11(5):511. PubMed ID: 22034726
    [No Abstract]   [Full Text] [Related]  

  • 11. A pilot study investigating plasma pharmacokinetics and tolerance of oral capecitabine in carcinoma-bearing dogs.
    Wetzel S; Fidel J; Whittington D; Villarino NF
    BMC Vet Res; 2024 Jan; 20(1):36. PubMed ID: 38297307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A valid formulation of the analysis of noninferiority trials under random effects meta-analysis.
    Brittain EH; Fay MP; Follmann DA
    Biostatistics; 2012 Sep; 13(4):637-49. PubMed ID: 22467938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of patients' knowledge of their treatment with capecitabine at the National Institute of Oncology in Rabat.
    Nouibi C; Cherif Chefchaouni A; Bechar H; Belahcen MJ; Rahali Y
    J Oncol Pharm Pract; 2023 Oct; 29(7):1708-1714. PubMed ID: 36637236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deprived social status is associated with decreased use of oral chemotherapy in patients with metastatic colorectal cancer: A retrospective cohort study on administrative databases in a French University Hospital.
    Gautier G; Lucas M; Vermeulin T; Di Fiore F; Merle V
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00888. PubMed ID: 34766736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to letter entitled: Re: Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France.
    Hill C
    Eur J Cancer; 2023 Aug; 189():112929. PubMed ID: 37327685
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral Chemotherapy for Treatment of Lung Cancer.
    Jonna S; Reuss JE; Kim C; Liu SV
    Front Oncol; 2020; 10():793. PubMed ID: 32426292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral versus intravenous fluoropyrimidines for colorectal cancer.
    Chionh F; Lau D; Yeung Y; Price T; Tebbutt N
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness.
    Twelves CJ
    Clin Colorectal Cancer; 2006 Nov; 6(4):278-87. PubMed ID: 17241512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient preferences for oral versus intravenous palliative chemotherapy.
    Liu G; Franssen E; Fitch MI; Warner E
    J Clin Oncol; 1997 Jan; 15(1):110-5. PubMed ID: 8996131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient preference for oral or intravenous chemotherapy: a randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer.
    Pfeiffer P; Mortensen JP; Bjerregaard B; Eckhoff L; Schønnemann K; Sandberg E; Aabo K; Jakobsen A
    Eur J Cancer; 2006 Nov; 42(16):2738-43. PubMed ID: 17011184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.